冠状动脉微血管疾病中的神经免疫相互作用:机制和治疗前景
Zhao Ge1,2, Guoyu Wu1,2, Jingguo Ma1,2
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Frontiers in immunology
|September 15, 2025
概括
冠状动脉微血管疾病 (CMVD) 涉及神经免疫相互作用. 未来的治疗需要精准医学整合神经免疫分析,以更好地分层患者和向治疗.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 冠状动脉微血管疾病 (CMVD) 是一种普遍的心血管疾病,其特征是内皮功能障碍和炎症.
- 涉及自主神经系统,免疫细胞和血管内皮的神经免疫相互作用在CMVD病变发生过程中至关重要.
- 现有的治疗方法往往缺乏分层,导致结果不理想.
研究的目的:
- 审查神经免疫相互作用在CMVD中的作用.
- 分析参与这些相互作用的信号通路 (例如NF-κB,MAPK).
- 评估目前对CMVD的临床试验和治疗策略.
主要方法:
- 关于神经免疫心血管电路的机制学研究的文献综述.
- 分析控制神经免疫相互作用的信号通路.
- 深入评估最近的临床试验,包括基于结果和机制的研究.
主要成果:
- 神经免疫电路在CMVD病变发生过程中发挥着关键作用.
- 特定的信号通路显著影响这些相互作用.
- 临床试验显示免疫调节的希望,但强调非分层方法的局限性.
结论:
- 整合神经免疫分析的精准医学框架对于未来的CMVD进展至关重要.
- 基于机制的患者分层对于有效的治疗策略至关重要.
- 神经免疫学镜头为CMVD提供了新的诊断和治疗前景.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
942
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
Psychoneuroimmunology: Cardiovascular Disease
405
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
405
Coronary Artery Disease II: Pathophysiology
375
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
375
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
Myocarditis I: Introduction
374
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
374
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215


